Clinical Trials Browser

OTHER × Thyroid Neoplasms × Ipilimumab × Clear all

NCT03246958 2025-06-19

Nivolumab Plus Ipilimumab in Thyroid Cancer

Phase 2 Completed

53 enrolled 19 charts

Thyroid Neoplasms